BUYOUT PROBABILITY ON FLEXION THERAPEUTICS LESSENED, TAKE PROFITS AND EXIT $FLXN

BUYOUT PROBABILITY ON FLEXION THERAPEUTICS LESSENED, TAKE PROFITS AND EXIT $FLXNThis post was just published on ZYX Buy Change Alert.  

125 of our portfolio companies have been bought out.  Long-time subscribers to The Arora Report have profited handsomely from buyouts.

FLXN has been a buyout candidate.  However the probability of a buyout has lessened based on recent developments.

FLXN is long from an average price of $18.75.  It is trading at $22.31 as of this writing.

Consider taking profits and exiting in the zone of $22 to $24.38.

A special note for subscribers to The Arora Report Market Blog and our free service Generate Wealth Investment Newsletter: a additional post was provided to paying subscribers that was not made available to the free subscribers.  This gave the paying subscribers an advantage of getting a lower average price.  For the sake of complete transparency and accuracy in calculating the performance of all trades that are made publicly available on the blog, $18.75 will not be used even though this provides for a better number.  A higher average entry price will be used consistent with what we made available to the free subscribers even though it shows less gain.

Please note that partial profits were previously taken.

You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE  30 day trial.

Check out our enviable performance in both bull and bear markets.

FREE: SUBSCRIBE TO ‘GENERATE WEALTH’ NEWSLETTER

Related Posts

TAKE PARTIAL PROFITS ON FLEXION THERAPEUTICS $FLXN

This post was just published on ZYX Buy Change Alert.  FLXN is long from 18.75.  The stock is trading at $23.19 as of ...

A SPECIAL NOTE FOR NEW SUBSCRIBERS, LONG-TERM INVESTMENTS AND/OR SHORT-TERM TRADES, AN IMPORTANT TIP $FLXN $XBI $IBB $LABU $LABD $SPY

This post was just published on ZYX Buy Change Alert.  Our subscribers have a wide range of interests. Some focus only on long-term ...

PLAN ON FLEXION THERAPEUTICS, QUICK DENIAL MAY MEAN HIGHER POTENTIAL OF A BUYOUT $FLXN $SNY

This post was just published on ZYX Buy Change Alert. A quick denial of a potential deal is not typical, as has happened ...

TAKE PROFITS ON FLEXION THERAPEUTICS RIGHT HERE AROUND $25.88, IF FILLED $FLXN $SYN

This post was just published on ZYX Buy Change Alert.   You are receiving less than 2% of the content from our paid services ...

FLEXION THERAPEUTICS: CHANGING THE BUY ZONE TO $20 TO $21.15, SNY DENIES THE DEAL $FLXN $SYN

This post was just published on ZYX Buy Change Alert. More later You are receiving less than 2% of the content from our paid ...

UPDATE ON FLEXION THERAPEUTICS $FLXN $SYN

This post was just published on ZYX Buy Change Alert. The stock has surged to over $26 as of this writing. Consider not ...

INTELLIGENCE: A NEW IDEA ON FLEXION THERAPEUTICS, RUMORS OF A BUYOUT $FLXN $SNY

This post was just published on ZYX Buy Change Alert. For us to recommend, a stock must pass at least four of the ...

Follow

Get every new post delivered to your Inbox

Join other followers